Skip to content
Menu

Akebia Therapeutics, Inc. AKBA

Full chart Compare
Set alert

Price alert · AKBA

All alert types
0.39 USD -0.04 (-8.71%)

Regular-session close

0.40 +0.01 +3.50%

After hours · Nov 20, 7:50 PM ET

0.3849 Day range 0.4331
0.361 52-week range 1.73
YTD
-76.06%
1 year
-74.97%

AKBA revenue history

Revenue is income from the company’s ordinary business activities.

236,196,000 USD

FY 2025 · Period ended

Coverage: complete. Values in USD; not inflation adjusted.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

Scroll the table to see all values →

Revenue · annual · USD
Fiscal periodPeriod endRevenueYoY changeYoY %
FY 20252025-12-31236,196,00076,016,00047.46%
FY 20242024-12-31160,180,000-34,443,000-17.70%
FY 20232023-12-31194,623,000-97,861,000-33.46%
FY 20222022-12-31292,484,00080,834,00038.19%
FY 20212021-12-31211,650,000-82,994,000-28.17%
FY 20202020-12-31294,644,000-40,357,000-12.05%
FY 20192019-12-31335,001,000127,259,00061.26%
FY 20182018-12-31207,742,00026,515,00014.63%
FY 20172017-12-31181,227,000179,692,00011706.32%
FY 20162016-12-311,535,0001,535,000Not meaningful
FY 20152015-12-3100Not meaningful
FY 20142014-12-3100Not meaningful
FY 20132013-12-2800Not meaningful
FY 20122012-12-310Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2026-08-07T06:01:41.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.